Summary of findings 7. Study funding/ Financial support.

Study name	Funding name/Financial support resource
Cubo 2006	Pfizer‐Eisai Inc.
Krupp 2004	the National Institutes of Health (grant HD38107‐01); the National Institutes for Disability and Rehabilitation Research (grant H133G990058); the National Multiple Sclerosis Society (grant RG3042‐A‐2); the National Center for Research Resources (grant M01‐RR10710‐02).
Krupp 2011	the National Institutes of Health (2 R01 HD38107); the National Center for Research Resources (M01 RR10710).
Mäurer 2013	Novartis Pharma GmbH.
Dichgans 2008	Eisai Medical Research (Ridgefield Park, NJ, USA).
Kertesz 2008	Janssen‐Ortho Inc., Canada; Johnson & Johnson Pharmaceutical Research and Development.
Sešok 2014	Pharmacy Brod, Ljubljana, Slovenia.